CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Bellemin Jean-Marc Chief Financial Officer | Option exercise | +18,850 | 28,354 | ||
| 2023-01-03 | Bellemin Jean-Marc Chief Financial Officer | Shares withheld for taxes | −10,553 | $6.11 | $64K | 17,801 |
| 2023-01-03 | Bellemin Jean-Marc Chief Financial Officer | Option exercise · Restricted Stock Units | −18,850 | 0 | ||
| 2022-12-21 | MCPEAK MERRILL A Director | Purchase | +10,000 | $6.15 | $62K | 70,150 |
| 2022-12-02 | Rothbaum Wayne P. Director | Purchase | +10,000,000 | $6.50 | $65.0M | 18,067,333 |
| 2022-11-29 | MCPEAK MERRILL A Director | Purchase | +10,000 | $6.31 | $63K | 238,633 |
| 2022-11-28 | Vogt Frederick G Interim CEO & General Counsel | Purchase | +1,000 | $5.98 | $6K | 2,000 |
| 2022-11-28 | MCPEAK MERRILL A Director | Purchase | +10,000 | $6.18 | $62K | 228,633 |
| 2022-11-23 | Dukes Iain D. Director | Purchase | +10,000 | $6.10 | $61K | 22,000 |
| 2022-08-23 | MCPEAK MERRILL A Director | Option exercise | +40,000 | $5.65 | $226K | 60,150 |
| 2022-08-23 | MCPEAK MERRILL A Director | Option exercise · Stock Option (right to buy) | +40,000 | 0 | ||
| 2022-06-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +19,690 | 19,690 | ||
| 2022-06-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −6,809 | $7.73 | $53K | 12,881 |
| 2022-06-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Grant or award · Restricted Stock Units | +19,690 | 19,690 | ||
| 2022-06-14 | Bellemin Jean-Marc Chief Financial Officer | Option exercise | +18,850 | 18,850 | ||
| 2022-06-14 | Bellemin Jean-Marc Chief Financial Officer | Shares withheld for taxes | −9,346 | $7.73 | $72K | 9,504 |
| 2022-06-14 | Bellemin Jean-Marc Chief Financial Officer | Grant or award · Restricted Stock Units | +18,850 | 18,850 | ||
| 2022-06-14 | BILINSKY IGOR Chief Operating Officer | Option exercise | +18,850 | 18,850 | ||
| 2022-06-14 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −9,346 | $7.73 | $72K | 9,504 |
| 2022-06-14 | BILINSKY IGOR Chief Operating Officer | Grant or award · Restricted Stock Units | +18,850 | 18,850 |
Page 20 of 23 · 446 trades